Articles
	12/24/2005	FDA’s Presents To Biotech Biotech and specialty pharmas found lots of shiny new products under the tree in 2005. In fact, the FDA’s been at least as generous this year as it was the last two.
	11/30/2005	The Monoclonal Maze Monoclonal antibody developers often must navigate a path through an intricate web of patent claims to reach their goal.
	10/05/2005	Biotech’s Old Soldiers Countless biotech companies have been founded over the years, but few old-timers remain today. They may have marched through the decades scoring financial and regulatory victories, but in the end those hard-won assets flagged them for acquisition.
	8/26/2005	Atopy’s No Utopia Atopic dermatitis usually begins in early childhood, often presages hay fever or asthma, and is ever more common. What’s going on to stop all the itching?
	7/28/2005	Sentries Of The Immune System Like lookouts of old, stationed at the castle walls to spot invaders and sound the alarm, toll-like receptors serve as the immune system’s early warning system.
	6/17/2005	Startup Maestros Of Academia Startups based on university technologies do not always begin with entrepreneurs shopping for technologies around which to build companies. Sometimes it is the universities themselves that take the first step.
	5/23/2005	Serono’s Global Aspirations Swiss biotech Serono, best known for its expertise in protein-based therapies, is developing a broad network of international alliances to help it bolster its pipeline in traditional areas and add skills in new ones.
	4/22/2005	Pharma's Buying Spree While big pharmas sign hundreds of partnerships with biotech firms, they very rarely buy them outright. Most years, there are only 5-7 such deals. But thanks to a confluence of factors, M&A activity could soar this year.
	3/03/2005	Tracking The Progress of RNA Drugs Antisense, aptamers, ribozymes: Firms developing RNA drugs have trekked a long, often lonely, trail in their quest for new therapies. That's changing rapidly, though, as those with gene-silencing skills join the pack.
	1/18/2005	Investors Fuel Biotech’s Future Stoked by fresh cash injections, biotech and specialty pharmas roared through 2004 full throttle. Companies logged nearly $21 billion in new capital for the year – enough to break all previous records, save one.
top
		Buzz
	10/17/2005	Financing Could Top $20B – Again
	8/17/2005	Drug Developers On A Roller Coaster Ride
	6/06/2005	Striking The Right Balance
	4/29/2005	First Signs Of A Drought
	2/17/2005	Deal-Making Heads Upstream
	1/05/2005	Red Herrings & Green Shoes
top
		Data Mining
	1/20/2005	Third Quarter 2004 Alliance Scorecard – Disease-Based Alliances Gain Ground
top
		Focal Point
	9/22/2005	Flu Vaccines Back In Vogue
	7/15/2005	Financing Pace Slow But Steady
	6/06/2005	Perspectives On A Changing World
	3/29/2005	The Next Step In Pharmacogenomics
	2/10/2005	Pharmas Spin Off Assets
top
		School Zone
	12/16/2005	Bayh-Dole: 25 Years Of Success
	9/19/2005	Lasker Awards: America’s Nobels
	6/17/2005	Introducing RecapIP
	5/01/2005	The Five Best Deals Of 2004
top
		Signals vs Noise
	10/07/2005	Financial Snapshot For September 2005: Reason To Smile
	7/08/2005	Financial Snapshot For June 2005: Some Resilience
	4/06/2005	Financial Snapshot For March 2005: Sliding South
	1/24/2005	Financial Snapshot For December 2004: Sideways
top
		Turn Signals
	11/08/2005	IPO: The Worst Financing Of All
	8/25/2005	Drug Sales Sparkle
	6/14/2005	Tracking Industry Growth
	5/13/2005	Sleuthing For Cancer Pathways & Markers
	3/17/2005	Drug Sales Ignited By Blockbusters
	1/07/2005	FDA Picks Up The Pace
top
		Trivia
	12/28/2005	ADHD
	12/21/2005	Tiny Tim
	12/14/2005	ACT
	12/07/2005	Fluoride
	11/30/2005	Lollypop
	11/23/2005	Tagamet
	11/16/2005	Corus
	11/09/2005	Tercica
	11/02/2005	Leukemia
	10/26/2005	Androclus
	10/19/2005	hGH
	10/12/2005	SSRI
	10/05/2005	The Pill
	9/28/2005	Transplants
	9/21/2005	Ether
	9/14/2005	Dropsy
	9/07/2005	Stars
	8/31/2005	PCR
	8/24/2005	Crixivan
	8/17/2005	Cancer Drug
	8/10/2005	Takhus
	7/27/2005	Receptors
	7/20/2005	WWE
	7/13/2005	Braces
	7/06/2005	Aptuit
	6/29/2005	Usher Syndrome
	6/22/2005	BIO 2009
	6/15/2005	Haptotaxis
	6/08/2005	Second Code
	6/01/2005	Yuppie Flu
	5/25/2005	Peter Pan
	5/18/2005	Angiostatin
	5/11/2005	Neurotensin
	5/04/2005	E. coli
	4/27/2005	Atsenti
	4/20/2005	Genographic Project
	4/13/2005	Chimp DNA
	4/06/2005	Symlin
	3/30/2005	Absinthe
	3/23/2005	BAY 43-9006
	3/16/2005	Ancient Protein
	3/09/2005	BRCA1
	3/02/2005	Oncogene
	2/23/2005	Monod
	2/16/2005	Yummy
	2/09/2005	A Smile In Your Heart
	2/02/2005	Retavase
	1/26/2005	Mouthful
	1/19/2005	Maps
	1/12/2005	NIH Royalty
	1/05/2005	Codons
top